Report Overview
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
The global Hereditary Angioedema Therapeutic market size was estimated at USD 2088.60 million in 2023 and is projected to reach USD 3267.98 million by 2032, exhibiting a CAGR of 5.10% during the forecast period.
North America Hereditary Angioedema Therapeutic market size was estimated at USD 592.85 million in 2023, at a CAGR of 4.37% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Hereditary Angioedema Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Therapeutic market in any manner.
Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Market Segmentation (by Type)
Intravenous
Subcutaneous
Oral
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Therapeutic Market
Overview of the regional outlook of the Hereditary Angioedema Therapeutic Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hereditary Angioedema Therapeutic Market Overview
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hereditary Angioedema Therapeutic Market Competitive Landscape
3.1 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2019-2025)
3.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2019-2025)
3.3 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Hereditary Angioedema Therapeutic Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hereditary Angioedema Therapeutic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hereditary Angioedema Therapeutic Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2025)
6.3 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2025)
6.4 Global Hereditary Angioedema Therapeutic Price by Type (2019-2025)
7 Hereditary Angioedema Therapeutic Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2019-2025)
7.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2019-2025)
7.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2025)
8 Hereditary Angioedema Therapeutic Market Consumption by Region
8.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Hereditary Angioedema Therapeutic Market Production by Region
9.1 Global Production of Hereditary Angioedema Therapeutic by Region (2019-2025)
9.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2019-2025)
9.3 Global Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Hereditary Angioedema Therapeutic Production
9.4.1 North America Hereditary Angioedema Therapeutic Production Growth Rate (2019-2025)
9.4.2 North America Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Hereditary Angioedema Therapeutic Production
9.5.1 Europe Hereditary Angioedema Therapeutic Production Growth Rate (2019-2025)
9.5.2 Europe Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Hereditary Angioedema Therapeutic Production (2019-2025)
9.6.1 Japan Hereditary Angioedema Therapeutic Production Growth Rate (2019-2025)
9.6.2 Japan Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Hereditary Angioedema Therapeutic Production (2019-2025)
9.7.1 China Hereditary Angioedema Therapeutic Production Growth Rate (2019-2025)
9.7.2 China Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 BioCryst Pharma
10.1.1 BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
10.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
10.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.1.4 BioCryst Pharma Business Overview
10.1.5 BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
10.1.6 BioCryst Pharma Recent Developments
10.2 Ionis Pharma
10.2.1 Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
10.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
10.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.2.4 Ionis Pharma Business Overview
10.2.5 Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
10.2.6 Ionis Pharma Recent Developments
10.3 Pharming Group
10.3.1 Pharming Group Hereditary Angioedema Therapeutic Basic Information
10.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
10.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
10.3.4 Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
10.3.5 Pharming Group Business Overview
10.3.6 Pharming Group Recent Developments
10.4 CSL Limited
10.4.1 CSL Limited Hereditary Angioedema Therapeutic Basic Information
10.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
10.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
10.4.4 CSL Limited Business Overview
10.4.5 CSL Limited Recent Developments
10.5 Shire
10.5.1 Shire Hereditary Angioedema Therapeutic Basic Information
10.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
10.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
10.5.4 Shire Business Overview
10.5.5 Shire Recent Developments
10.6 Attune Pharma
10.6.1 Attune Pharma Hereditary Angioedema Therapeutic Basic Information
10.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
10.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.6.4 Attune Pharma Business Overview
10.6.5 Attune Pharma Recent Developments
10.7 Adverum Biotechnologies
10.7.1 Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
10.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
10.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
10.7.4 Adverum Biotechnologies Business Overview
10.7.5 Adverum Biotechnologies Recent Developments
10.8 KalVista Pharma
10.8.1 KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
10.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
10.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.8.4 KalVista Pharma Business Overview
10.8.5 KalVista Pharma Recent Developments
11 Hereditary Angioedema Therapeutic Market Forecast by Region
11.1 Global Hereditary Angioedema Therapeutic Market Size Forecast
11.2 Global Hereditary Angioedema Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Therapeutic by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Therapeutic by Type (2025-2032)
12.1.2 Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Hereditary Angioedema Therapeutic by Type (2025-2032)
12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Application (2025-2032)
12.2.1 Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Therapeutic Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Therapeutic Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2022)
Table 10. Global Market Hereditary Angioedema Therapeutic Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Hereditary Angioedema Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Therapeutic Product Type
Table 13. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Global Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 23. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Therapeutic Sales (K MT) by Type (2019-2025)
Table 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2025)
Table 26. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2019-2025)
Table 27. Global Hereditary Angioedema Therapeutic Market Size Share by Type (2019-2025)
Table 28. Global Hereditary Angioedema Therapeutic Price (USD/MT) by Type (2019-2025)
Table 29. Global Hereditary Angioedema Therapeutic Sales (K MT) by Application
Table 30. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 31. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2025) & (K MT)
Table 32. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2025)
Table 33. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2025) & (M USD)
Table 34. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2025)
Table 35. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2025)
Table 36. Global Hereditary Angioedema Therapeutic Sales by Region (2019-2025) & (K MT)
Table 37. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2025)
Table 38. North America Hereditary Angioedema Therapeutic Sales by Country (2019-2025) & (K MT)
Table 39. Europe Hereditary Angioedema Therapeutic Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Hereditary Angioedema Therapeutic Sales by Region (2019-2025) & (K MT)
Table 41. South America Hereditary Angioedema Therapeutic Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region (2019-2025) & (K MT)
Table 43. Global Hereditary Angioedema Therapeutic Production (K MT) by Region (2019-2025)
Table 44. Global Hereditary Angioedema Therapeutic Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2019-2025)
Table 46. Global Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
Table 52. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 53. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. BioCryst Pharma Business Overview
Table 55. BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 56. BioCryst Pharma Recent Developments
Table 57. Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
Table 58. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 59. Ionis Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Ionis Pharma Business Overview
Table 61. Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 62. Ionis Pharma Recent Developments
Table 63. Pharming Group Hereditary Angioedema Therapeutic Basic Information
Table 64. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 65. Pharming Group Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
Table 67. Pharming Group Business Overview
Table 68. Pharming Group Recent Developments
Table 69. CSL Limited Hereditary Angioedema Therapeutic Basic Information
Table 70. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 71. CSL Limited Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. CSL Limited Business Overview
Table 73. CSL Limited Recent Developments
Table 74. Shire Hereditary Angioedema Therapeutic Basic Information
Table 75. Shire Hereditary Angioedema Therapeutic Product Overview
Table 76. Shire Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Shire Business Overview
Table 78. Shire Recent Developments
Table 79. Attune Pharma Hereditary Angioedema Therapeutic Basic Information
Table 80. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 81. Attune Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Attune Pharma Business Overview
Table 83. Attune Pharma Recent Developments
Table 84. Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
Table 85. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 86. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Adverum Biotechnologies Business Overview
Table 88. Adverum Biotechnologies Recent Developments
Table 89. KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
Table 90. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 91. KalVista Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. KalVista Pharma Business Overview
Table 93. KalVista Pharma Recent Developments
Table 94. Global Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Hereditary Angioedema Therapeutic Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Hereditary Angioedema Therapeutic Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Hereditary Angioedema Therapeutic Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2019-2032
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2019-2032)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Therapeutic Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Therapeutic Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2019-2025)
Figure 19. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Therapeutic by Type (2019-2025)
Figure 21. Market Size Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 24. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2025)
Figure 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2025)
Figure 27. Global Hereditary Angioedema Therapeutic Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2025)
Figure 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2025)
Figure 30. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Hereditary Angioedema Therapeutic Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 50. South America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Hereditary Angioedema Therapeutic Production Market Share by Region (2019-2025)
Figure 62. North America Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2019-2025)
Figure 65. China Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Hereditary Angioedema Therapeutic Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Hereditary Angioedema Therapeutic Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Hereditary Angioedema Therapeutic Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2025-2032)
Figure 70. Global Hereditary Angioedema Therapeutic Sales Forecast by Application (2025-2032)
Figure 71. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2025-2032)
